Erik J Tillman

5PUBLICATIONS
6CO-AUTHORS
Medical virologyMolecular targetsNutritional epidemiologyEpigenetics (incl. genome methylation and epigenomics)Host-parasite interactions
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 09, 2025
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH.

Mazen Noureddin, Mary E Rinella, Naga P Chalasani

|Nov 13, 2021
Efruxifermin, a long-acting Fc-fusion FGF21 analogue, reduces body weight gain but does not increase sympathetic tone or urine volume in Sprague Dawley rats.

Erik J Tillman, William J Brock, Tim Rolph

|Jul 09, 2021
Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial.

Stephen A Harrison, Peter J Ruane, Bradley L Freilich

|Feb 22, 2019
Global transcriptional regulation of innate immunity by ATF-7 in C. elegans.

Marissa Fletcher, Erik J Tillman, Vincent L Butty

|Oct 06, 2018
Endoplasmic Reticulum Homeostasis Is Modulated by the Forkhead Transcription Factor FKH-9 During Infection of Caenorhabditis elegans.

Erik J Tillman, Claire E Richardson, Douglas J Cattie

Pageof 1

Frequent Collaborators

1 joint publications

Vincent L Butty

1 joint publications

Stuart S Levine

1 joint publications

Dennis H Kim

1 joint publications

Kitty Yale